68Ga-DOTATATE PET: The Future of Meningioma Treatment

Rahul N. Prasad; Haley K. Perlow; Joseph Bovi; Steve E. Braunstein; Jana Ivanidze; John A. Kalapurakal; Christopher Kleefisch; Jonathan P.S. Knisely; Minesh P. Mehta; Daniel M. Prevedello; David R. Raleigh; Mark V. Mishra; David Roberge; C. Leland Rogers; Joshua D. Palmer

doi:10.1016/j.ijrobp.2022.04.041

⁶⁸Ga-DOTATATE PET: The Future of Meningioma Treatment

Rahul N. Prasad, Haley K. Perlow, Joseph Bovi, Steve E. Braunstein, Jana Ivanidze, John A. Kalapurakal, Christopher Kleefisch, Jonathan P.S. Knisely, Minesh P. Mehta, Daniel M. Prevedello, David R. Raleigh, Mark V. Mishra, David Roberge, C. Leland Rogers, Joshua D. Palmer^*

^*Corresponding author for this work

Radiation Oncology

Research output: Contribution to journal › Editorial › peer-review

19 Scopus citations

Original language	English (US)
Pages (from-to)	868-871
Number of pages	4
Journal	International Journal of Radiation Oncology Biology Physics
Volume	113
Issue number	4
DOIs	https://doi.org/10.1016/j.ijrobp.2022.04.041
State	Published - Jul 15 2022

Funding

JDP discloses Honoraria from Huron Consulting group, Advisory Board Novocure and research support from Varian Medical Systems, Genentech and Kroger outside the submitted work. MPM discloses Consultant for Karyopharm, Sapience, Zap, Mevion, Xoft, Tocagen, Board of Directors for Oncoceutics (2/10/18-1/8/21) and stock in Chimerix, outside of submitted work. JI reports grant support from Advanced Accelerator Applications, Radiological Society of North America, Associate Editor of Radiology: Imaging Center. JDP discloses Honoraria from Huron Consulting group, Advisory Board Novocure and research support from Varian Medical Systems, Genentech and Kroger outside the submitted work. MPM discloses Consultant for Karyopharm, Sapience, Zap, Mevion, Xoft, Tocagen, Board of Directors for Oncoceutics (2/10/18-1/8/21) and stock in Chimerix, outside of submitted work. JI reports grant support from Advanced Accelerator Applications, Radiological Society of North America, Associate Editor of Radiology: Imaging Center.

ASJC Scopus subject areas

Radiation
Oncology
Radiology Nuclear Medicine and imaging
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ijrobp.2022.04.041

Cite this

Prasad, R. N., Perlow, H. K., Bovi, J., Braunstein, S. E., Ivanidze, J., Kalapurakal, J. A., Kleefisch, C., Knisely, J. P. S., Mehta, M. P., Prevedello, D. M., Raleigh, D. R., Mishra, M. V., Roberge, D., Rogers, C. L., & Palmer, J. D. (2022). ⁶⁸Ga-DOTATATE PET: The Future of Meningioma Treatment. International Journal of Radiation Oncology Biology Physics, 113(4), 868-871. https://doi.org/10.1016/j.ijrobp.2022.04.041

@article{df8227f56c7b46e1ad9118e68cb21e6c,

title = "68Ga-DOTATATE PET: The Future of Meningioma Treatment",

author = "Prasad, {Rahul N.} and Perlow, {Haley K.} and Joseph Bovi and Braunstein, {Steve E.} and Jana Ivanidze and Kalapurakal, {John A.} and Christopher Kleefisch and Knisely, {Jonathan P.S.} and Mehta, {Minesh P.} and Prevedello, {Daniel M.} and Raleigh, {David R.} and Mishra, {Mark V.} and David Roberge and Rogers, {C. Leland} and Palmer, {Joshua D.}",

note = "Funding Information: JDP discloses Honoraria from Huron Consulting group, Advisory Board Novocure and research support from Varian Medical Systems, Genentech and Kroger outside the submitted work. MPM discloses Consultant for Karyopharm, Sapience, Zap, Mevion, Xoft, Tocagen, Board of Directors for Oncoceutics (2/10/18-1/8/21) and stock in Chimerix, outside of submitted work. JI reports grant support from Advanced Accelerator Applications, Radiological Society of North America, Associate Editor of Radiology: Imaging Center. Funding Information: JDP discloses Honoraria from Huron Consulting group, Advisory Board Novocure and research support from Varian Medical Systems, Genentech and Kroger outside the submitted work. MPM discloses Consultant for Karyopharm, Sapience, Zap, Mevion, Xoft, Tocagen, Board of Directors for Oncoceutics (2/10/18-1/8/21) and stock in Chimerix, outside of submitted work. JI reports grant support from Advanced Accelerator Applications, Radiological Society of North America, Associate Editor of Radiology: Imaging Center. ",

year = "2022",

month = jul,

day = "15",

doi = "10.1016/j.ijrobp.2022.04.041",

language = "English (US)",

volume = "113",

pages = "868--871",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "4",

}

Prasad, RN, Perlow, HK, Bovi, J, Braunstein, SE, Ivanidze, J, Kalapurakal, JA, Kleefisch, C, Knisely, JPS, Mehta, MP, Prevedello, DM, Raleigh, DR, Mishra, MV, Roberge, D, Rogers, CL & Palmer, JD 2022, '⁶⁸Ga-DOTATATE PET: The Future of Meningioma Treatment', International Journal of Radiation Oncology Biology Physics, vol. 113, no. 4, pp. 868-871. https://doi.org/10.1016/j.ijrobp.2022.04.041

TY - JOUR

T1 - 68Ga-DOTATATE PET

T2 - The Future of Meningioma Treatment

AU - Prasad, Rahul N.

AU - Perlow, Haley K.

AU - Bovi, Joseph

AU - Braunstein, Steve E.

AU - Ivanidze, Jana

AU - Kalapurakal, John A.

AU - Kleefisch, Christopher

AU - Knisely, Jonathan P.S.

AU - Mehta, Minesh P.

AU - Prevedello, Daniel M.

AU - Raleigh, David R.

AU - Mishra, Mark V.

AU - Roberge, David

AU - Rogers, C. Leland

AU - Palmer, Joshua D.

N1 - Funding Information: JDP discloses Honoraria from Huron Consulting group, Advisory Board Novocure and research support from Varian Medical Systems, Genentech and Kroger outside the submitted work. MPM discloses Consultant for Karyopharm, Sapience, Zap, Mevion, Xoft, Tocagen, Board of Directors for Oncoceutics (2/10/18-1/8/21) and stock in Chimerix, outside of submitted work. JI reports grant support from Advanced Accelerator Applications, Radiological Society of North America, Associate Editor of Radiology: Imaging Center. Funding Information: JDP discloses Honoraria from Huron Consulting group, Advisory Board Novocure and research support from Varian Medical Systems, Genentech and Kroger outside the submitted work. MPM discloses Consultant for Karyopharm, Sapience, Zap, Mevion, Xoft, Tocagen, Board of Directors for Oncoceutics (2/10/18-1/8/21) and stock in Chimerix, outside of submitted work. JI reports grant support from Advanced Accelerator Applications, Radiological Society of North America, Associate Editor of Radiology: Imaging Center.

PY - 2022/7/15

Y1 - 2022/7/15

UR - http://www.scopus.com/inward/record.url?scp=85133286952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133286952&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2022.04.041

DO - 10.1016/j.ijrobp.2022.04.041

M3 - Editorial

C2 - 35772444

AN - SCOPUS:85133286952

SN - 0360-3016

VL - 113

SP - 868

EP - 871

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 4

ER -